Autolus Therapeutics Ltd reported $277.27M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
AstraZeneca USD 25.96B 177M Mar/2026
Autolus Therapeutics Ltd USD 277.27M 7.07M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Novartis USD 37.45B 7.86B Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Silence Therapeutics USD 93K 0 Mar/2024